首页 › 基金 › Knott David M Jr › SNDX
Knott David M Jr 对 SNDX 的持仓历史
SYNDAX PHARMACEUTICALS INC · 医疗保健
Knott David M Jr 在 Q3 2026 的 13F 申报中披露持有 SNDX(SYNDAX PHARMACEUTICALS INC)428,294 股,市值约 US$8.1M,约占其申报组合的 4.40%,在其申报持仓中市值排名第 5 位。 Knott David M Jr 最近 11 个申报季度中有 11 个季度披露了 SNDX 持仓,最早可追溯至 Q1 2024。
最后更新: 2026-11-13 · 来源: SEC EDGAR Form 13F-HR
Knott David M Jr 对 SNDX 的持仓演变
Knott David M Jr 于 Q1 2024 首次披露 SNDX 持仓:65,475 股(约 US$1.6M)。 该持仓在 Q1 2026 达到峰值 422,000 股,市值约 US$9.9M。 在 11 次申报中,Knott David M Jr 7 次增持、2 次减持、1 次保持不变。 最近一期申报(Q3 2026)显示持股 428,294 股、市值约 US$8.1M,环比减持 -8,951 股。。 持仓曾出现大幅变动:Q2 2024 增持约 59% (随后一个季度股价下跌 6%)、Q2 2025 增持约 176% (随后一个季度股价上涨 64%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q1 2024 | 65.47K | $1.56M | 新进 |
| Q2 2024 | 103.83K | $2.13M | 增持 |
| Q3 2024 | 122.14K | $2.35M | 增持 |
| Q4 2024 | 128.00K | $1.69M | 增持 |
| Q1 2025 | 128.00K | $1.57M | 持有 |
| Q2 2025 | 352.78K | $3.30M | 增持 |
| Q3 2025 | 428.00K | $6.58M | 增持 |
| Q4 2025 | 415.00K | $8.72M | 减持 |
| Q1 2026 | 422.00K | $9.86M | 增持 |
| Q2 2026 | 437.25K | $9.56M | 增持 |
| Q3 2026 | 428.29K | $8.05M | 减持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 SNDX 与 13F 数据
SNDX(SYNDAX PHARMACEUTICALS INC)属于医疗保健行业。我们追踪的基金中还有 40 只申报持有 SNDX,申报仓位最大的包括:Kynam Capital Management, LP (US$176.0M), DEERFIELD MANAGEMENT COMPANY, L.P. (US$82.6M), Eversept Partners, LP (US$61.2M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 SNDX 的基金
- Kynam Capital Management, LP 8.05M 股 · $175.99M · Q2 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 3.78M 股 · $82.63M · Q2 2026
- Eversept Partners, LP 2.80M 股 · $61.17M · Q2 2026
- KINGDON CAPITAL MANAGEMENT, L.L.C. 2.50M 股 · $54.65M · Q2 2026
- Elmind Capital, LP 1.85M 股 · $40.55M · Q2 2026
- Soleus Capital Management, L.P. 1.63M 股 · $35.59M · Q2 2026
- ORBIMED ADVISORS LLC 1.54M 股 · $33.71M · Q2 2026
- MPM BioImpact LLC 1.33M 股 · $29.15M · Q2 2026
- Catalio Capital Management, LP 1.22M 股 · $26.58M · Q2 2026
- Prosight Management, LP 1.20M 股 · $26.23M · Q2 2026
- Aisling Capital Management LP 1.32M 股 · $24.76M · Q3 2026
- Trails Edge Capital Partners, LP 1.11M 股 · $24.26M · Q2 2026
更多关于 Knott David M Jr
常见问题
How long has Knott David M Jr held SNDX?
Knott David M Jr has disclosed SNDX holdings in 11 of the last 11 reported quarters, going back to Q1 2024.
What is Knott David M Jr's current position in SNDX?
As of Q3 2026, Knott David M Jr holds 428.29K shares of SNDX (SYNDAX PHARMACEUTICALS INC), valued at $8.05M, representing 4.40% of its reported portfolio and ranking #5.
Has Knott David M Jr been buying or selling SNDX?
In the latest 13F filing (Q3 2026), Knott David M Jr reduced its position in SNDX. The position peaked in Q1 2026 at 422.00K shares.
Which other funds hold SNDX?
Other major institutional holders of SNDX include Kynam Capital Management, LP, DEERFIELD MANAGEMENT COMPANY, L.P., Eversept Partners, LP, among 40 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.